Jiaxing ZMAX Optech (688307.SH) net profit for the year 2024 increased by 47.53% year-on-year to 53.5979 million yuan.
Zhongrun Optics (688307.SH) released its 2024 annual performance report. During the reporting period, the company achieved total operating revenue...
Jiaxing ZMAX Optech (688307.SH) released its 2024 annual performance report. During the reporting period, the company achieved a total operating revenue of 455 million yuan, a year-on-year increase of 20.06%, and a net profit attributable to the owners of the parent company of 53.5979 million yuan, a year-on-year increase of 47.53%.
During the reporting period, the company strengthened the transformation and market promotion of new products and technologies, with a continuous enrichment of product types, expansion of application areas, and improvement of customer quality. Revenue from products in various fields showed a growth trend, with smart monitoring and sensing areas recovering growth, rapid growth in video communication and interaction areas, significant growth in intelligent monitoring and recognition areas, and stable growth in high-definition shooting and display areas. At the same time, the company continued to strengthen cost optimization and control, continued to promote the mass production of new products, and the overall gross profit margin remained stable at a high level. By comprehensively improving management efficiency and strengthening cost management, administrative expenses decreased, enhancing the company's profitability.
Related Articles

Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"

CONCORD HC GP(02453): Income and profits double, proton therapy drives hospital business explosion
Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"

CONCORD HC GP(02453): Income and profits double, proton therapy drives hospital business explosion

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


